Sens. Dianne Feinstein (D-Calif.) and Jim Talent (R-Mo.) are leading a bipartisan group of lawmakers backing a bill that would require customers to talk to a pharmacy worker and present ID to buy drugs containing pseudoephedrine, such as Sudafed.

The measure is supported by local law-enforcement officials, but not the drug industry. "It will limit access for the legitimate consumers to cough and cold products," said Mary Ann Wagner, vice president for pharmacy regulatory affairs at the National Association of Chain Drug Stores. "They're going to have to wait in line with everybody else, take the pharmacist away from their prescription customers to police the sales of the pseudoephedrine products."

Buyers would be limited to purchasing nine grams of the drug -- or 366 30-mg. pills -- per month. "Do you know a legitimate consumer that needs more than 300 pills at once, or a family that does? That's baloney," Feinstein said. "... The pharmaceutical companies are going to oppose anything."

The federal legislation is modeled on an Oklahoma bill passed last year, and also contains grant funding for meth treatment.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:
Comment: (limit 200 words)
Enter this word (help):	Change

GUIDELINES: 
To keep this feature useful for everyone, please:

1. Keep it clean, courteous, focused, and on-topic. Comments are meant for thoughtful discussion of the article published above.
   
   
2. Do not post personal requests for help or general promotions for your organization (Get help).
   
   
3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.